BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17572677)

  • 1. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population.
    Hoffmann A; Kerr S; Jellusova J; Zhang J; Weisel F; Wellmann U; Winkler TH; Kneitz B; Crocker PR; Nitschke L
    Nat Immunol; 2007 Jul; 8(7):695-704. PubMed ID: 17572677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Siglec-G regulates B1 cell survival and selection.
    Jellusova J; Düber S; Gückel E; Binder CJ; Weiss S; Voll R; Nitschke L
    J Immunol; 2010 Sep; 185(6):3277-84. PubMed ID: 20729333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.
    Hutzler S; Özgör L; Naito-Matsui Y; Kläsener K; Winkler TH; Reth M; Nitschke L
    J Immunol; 2014 Jun; 192(11):5406-14. PubMed ID: 24790146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice.
    Müller J; Lunz B; Schwab I; Acs A; Nimmerjahn F; Daniel C; Nitschke L
    J Immunol; 2015 Jul; 195(1):51-60. PubMed ID: 25987743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Siglec-G is a B-1 cell inhibitory receptor and also controls B cell tolerance.
    Nitschke L
    Ann N Y Acad Sci; 2015 Dec; 1362():117-21. PubMed ID: 26194636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for lysosomal-associated protein transmembrane 5 in the negative regulation of surface B cell receptor levels and B cell activation.
    Ouchida R; Kurosaki T; Wang JY
    J Immunol; 2010 Jul; 185(1):294-301. PubMed ID: 20519653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
    Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
    J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells.
    Gruber S; Hendrikx T; Tsiantoulas D; Ozsvar-Kozma M; Göderle L; Mallat Z; Witztum JL; Shiri-Sverdlov R; Nitschke L; Binder CJ
    Cell Rep; 2016 Mar; 14(10):2348-61. PubMed ID: 26947073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-α-producing PDCA-1+ Siglec-H- B cells mediate innate immune defense by activating NK cells.
    Bao Y; Han Y; Chen Z; Xu S; Cao X
    Eur J Immunol; 2011 Mar; 41(3):657-68. PubMed ID: 21287550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts.
    Gieseke F; Mang P; Viebahn S; Sonntag I; Kruchen A; Erbacher A; Pfeiffer M; Handgretinger R; Müller I
    Eur J Immunol; 2012 Aug; 42(8):2176-86. PubMed ID: 22585296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T; Gerlach J; Muller K; Marinkovic D; Hess J; Nitschke L; Wirth T
    Eur J Immunol; 2002 Sep; 32(9):2481-9. PubMed ID: 12207332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human-specific expression of Siglec-6 in the placenta.
    Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
    Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scarcity of lambda 1 B cells in mice with a single point mutation in C lambda 1 is due to a low BCR signal caused by misfolded lambda 1 light chain.
    Volgina VV; Sun T; Bozek G; Martin TE; Storb U
    Mol Immunol; 2007 Feb; 44(6):1417-28. PubMed ID: 16860389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
    Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
    J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.
    Loschko J; Heink S; Hackl D; Dudziak D; Reindl W; Korn T; Krug AB
    J Immunol; 2011 Dec; 187(12):6346-56. PubMed ID: 22079988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of Bruton's tyrosine kinase induces the formation of autoreactive IgM plasma cells.
    Kersseboom R; Kil L; Flierman R; van der Zee M; Dingjan GM; Middendorp S; Maas A; Hendriks RW
    Eur J Immunol; 2010 Sep; 40(9):2643-54. PubMed ID: 20623551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
    Gerlach J; Ghosh S; Jumaa H; Reth M; Wienands J; Chan AC; Nitschke L
    Eur J Immunol; 2003 Dec; 33(12):3418-26. PubMed ID: 14635051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signaling through murine CD38 is impaired in antigen receptor-unresponsive B cells.
    Lund FE; Solvason NW; Cooke MP; Health AW; Grimaldi JC; Parkhouse RM; Goodnow CC; Howard MC
    Eur J Immunol; 1995 May; 25(5):1338-45. PubMed ID: 7774637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.